⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21526247 | 0.72 | — | — | |
| SCHEMBL24265384 | 0.65 | — | — | |
| SCHEMBL11185221 | 0.65 | — | — | |
| SCHEMBL3897196 | 0.65 | — | — | |
| SCHEMBL5114 | 0.64 | — | — | |
| SCHEMBL21526261 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL10469621 | 0.62 | — | — | |
| SCHEMBL8844832 | 0.61 | — | — | |
| SCHEMBL1844747 | 0.61 | — | — | |
| SCHEMBL5211748 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3150600-B1 | DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR | QILU PHARMACEUTICAL CO LTD (CN) | 2018-06-27 | — | — | EP | claimed |
| US-9938301-B2 | Dihydropyrimido fused ring derivative as HBV inhibitor | QILU PHARMACEUTICAL CO., LTD. (CN) | 2018-04-10 | — | — | US | claimed |
| US-20170197986-A1 | DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR | MEDSHINE DISCOVERY INC. (CN) | 2017-07-13 | — | — | US | claimed |
| EP-3150600-A1 | DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR | Medshine Discovery Inc. (CN) | 2017-04-05 | — | — | EP | claimed |
| CN-109963922-B | Aldehyde scavenger and method for removing aldehyde | 东曹株式会社 | 2022-09-23 | — | — | CN | disclosed |
| US-20200061225-A1 | ALDEHYDE SCAVENGER AND METHOD FOR REMOVING ALDEHYDES | TOSOH CORPORATION (JP) | 2020-02-27 | — | — | US | disclosed |
| CN-106459061-B | Dihydropyrimidino-cyclic derivatives as HBV inhibitors | 齐鲁制药有限公司 | 2020-01-21 | — | — | CN | disclosed |
| EP-3564334-A1 | ALDEHYDE SCAVENGER AND ALDEHYDE REMOVAL METHOD | Tosoh Corporation (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-3150600-B1 | DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR | QILU PHARMACEUTICAL CO LTD (CN) | 2018-06-27 | — | — | EP | disclosed |
| US-9938301-B2 | Dihydropyrimido fused ring derivative as HBV inhibitor | QILU PHARMACEUTICAL CO., LTD. (CN) | 2018-04-10 | — | — | US | disclosed |
| US-20170197986-A1 | DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR | MEDSHINE DISCOVERY INC. (CN) | 2017-07-13 | — | — | US | disclosed |
| EP-3150600-A1 | DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR | Medshine Discovery Inc. (CN) | 2017-04-05 | — | — | EP | disclosed |
| US-9341635-B2 | Mass labels | ELECTROPHORETICS LIMITED (GB) | 2016-05-17 | — | — | US | disclosed |
| EP-2467350-B1 | MASS LABELS | ELECTROPHORETICS LTD (GB) | 2015-11-11 | — | — | EP | disclosed |
| US-20150065392-A1 | MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2015-03-05 | — | — | US | disclosed |
| US-20120283137-A1 | MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2012-11-08 | — | — | US | disclosed |
| EP-2467350-A1 | MASS LABELS | Electrophoretics Limited (GB) | 2012-06-27 | — | — | EP | disclosed |
| WO-2011036059-A1 | MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2011-03-31 | — | — | WO | disclosed |